Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
0.6177
-0.0367 (-5.61%)
Apr 24, 2025, 4:00 PM EDT - Market closed

Jupiter Neurosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-2.44-4.78-4.96-4.2-1.65
Upgrade
Other Amortization
0.10.020.560.08-
Upgrade
Stock-Based Compensation
1.841.20.821.430.56
Upgrade
Other Operating Activities
-0.840.740.780.18-0.13
Upgrade
Change in Accounts Receivable
---0.13-0.13
Upgrade
Change in Accounts Payable
-0.150.16-0.06-0.160.19
Upgrade
Change in Other Net Operating Assets
-2.422.181.610.810.9
Upgrade
Operating Cash Flow
-3.91-0.48-1.25-1.74-0.25
Upgrade
Short-Term Debt Issued
0.140.390.980.530.02
Upgrade
Total Debt Issued
0.140.390.980.530.02
Upgrade
Short-Term Debt Repaid
-2.36----0.25
Upgrade
Total Debt Repaid
-2.36----0.25
Upgrade
Net Debt Issued (Repaid)
-2.220.390.980.53-0.24
Upgrade
Issuance of Common Stock
0.150.06-1.330.7
Upgrade
Other Financing Activities
9.73----
Upgrade
Financing Cash Flow
7.650.450.981.860.46
Upgrade
Net Cash Flow
3.74-0.04-0.270.120.21
Upgrade
Cash Interest Paid
0.150.030.080-
Upgrade
Levered Free Cash Flow
-2.92-3.12-0.830.25-0.6
Upgrade
Unlevered Free Cash Flow
-2.81-3-0.920.24-0.59
Upgrade
Change in Net Working Capital
2.771.78-0.41-1.26-0
Upgrade
Updated Dec 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q